Abstract
As IgG4-related disease (IgG4-RD) emerged and then began to come into sharper clinical focus during the first decade of the new century, those who have studied the disease have been privileged to appreciate many “Eureka” moments. One such moment was the observation of the substantial effect of B cell depletion on the clinical features and laboratory manifestations on IgG4-RD. Investigations of the use of this treatment strategy and studies of its mechanistic effects have led to important observations and are likely to yield important additional information about the nature of this disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kamisawa T, Shimosegawa T, Okazaki K, et al. Gut. 2009;58:1504–7.
Deshpande V, Zen Y, Ferry JA, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9): 1181–92.
Isaacs JD, Cohen SB, Emery P et al. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis. 2013;329–36.
Stone JH, Merkel PA, Spiera R, et al. Rituximab compared with cyclophosphamide for remission induction in ANCA-associated vasculitis. N Engl J Med. 2010;363:221–32.
Ahmed AR, Spigelman X, Cavacini LA, Posner MR. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med. 2006;355:1772–9.
Beck Jr LH, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21.
Stone JH. IgG4: a tantalizing connection between membranous glomerulonephritis and systemic disease. Kidney Int. 2012;83: 348–50.
Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol. 2003;98:2811–2.
Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to swift decline of serum IgG4 levels and prompt clinical improvement in IgG4-related disease. Arthritis Rheum. 2010;62:1755–62.
Khosroshahi A, Carruthers MD, Deshpande V, Leb L, Reed J, Stone JH. Cutaneous IgG4-related disease. Am J Med. 2011;124:e7–8.
Khosroshahi A, Carruthers MD, Deshpande V, et al. Rituximab for the treatment of IgG4-related systemic disease: lessons from a series of ten consecutive cases. Medicine (Baltimore). 2012;91:57–66.
Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD responder index. Int J Rheumatol. 2012;2012:259408.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Stone, J.H. (2014). B Cell Depletion in IgG4-Related Disease. In: Umehara, H., Okazaki, K., Stone, J., Kawa, S., Kawano, M. (eds) IgG4-Related Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54228-5_9
Download citation
DOI: https://doi.org/10.1007/978-4-431-54228-5_9
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54227-8
Online ISBN: 978-4-431-54228-5
eBook Packages: MedicineMedicine (R0)